Prescription Drug Monitoring Program
The Pennsylvania Prescription Drug Monitoring Program (PA PDMP) seeks to integrate the PDMP system with the electronic health records (EHRs) and pharmacy management systems of all eligible health care entities in Pennsylvania. The aim is to provide near-instant and seamless access to critical prescription history information to both prescribers and pharmacists across the commonwealth.
All health care entities in Pennsylvania that are legally authorized to prescribe, administer, or dispense controlled substances are eligible to apply for integration. This includes ambulatory care units, acute care facilities, emergency care units, physician practices, pharmacies, drug treatment facilities, and others.
How to Apply
To apply, please complete the online Integration Request Form. We request that only those authorized to make decisions relating to IT system integration on behalf of their organization fill out the form. Once the form is submitted, an overview of the next steps will be sent via email.
Meaningful Use (MU) provides incentive payments to eligible professionals (EP) and eligible hospitals (EH) that are able to demonstrate the "meaningful use" of electronic health records technology. The PA PDMP meets the definition of a specialized registry. EPs and EHs can meet the MU Stage 2 Specialized Registry objective by completing the following objective:
Successful ongoing submission of patient identifiers to the PDMP system and receipt of corresponding PDMP data using Certified Electronic Health Record Technology (CEHRT).
EPs and EHs can register their intent to complete this objective by filling out the online Integration Request Form. EPs and EHs will receive an electronic acknowledgement from the PA PDMP Office once integration is completed.
There are no certification and standards criteria specified by the Office of National Coordinator for Health Information Technology 2015 Edition Electronic Health Record (EHR) Technology Certification Criteria corresponding to this particular objective. For more information, please see the CMS FAQ on data submission to PDMPs for MU Stage 2.
Please see the Meaningful Use Public Health Reporting Declaration of Readiness document for more information.